ERBB2 and Autoimmunity: The adoptive transfer of T cells genetically modified with a chimeric antigen receptor specific for the Her2 antigen into Her2 tumor bearing mice have demonstrated both tumor regression and prolonged survival in the absence of autoimmunity [22,23].